ZURA (zurabio.com) Bozor qiymatining balans qiymatiga nisbati
Zura Bio Limited (ZURA) kompaniyasining ushbu kunlik narxlar grafigi faoliyati biofarmatsevtika patentlari bilan himoyalangan kompaniya dinamikasini aks ettiradi, shu bilan birga yuqori sinov xarajatlari yangi raqobatchilar uchun kirishning sezilarli to'siqlarini yaratadi. Xatarlar erta bosqichdagi sinovlar va potentsial moliyalashtirish yetishmovchiliklari bilan bog'liq bo'lib, ushbu ko'rsatkich 2.08 darajasida turibdi. Autoimmun kasalliklar uchun keng ko'lamli antitanalar sinovlarining kutilayotgan ishga tushirilishi katalizator vazifasini o'taydi, garchi tadqiqot va ishlanmalar (R&D) xarajatlari allaqachon narxga kiritilgan bo'lsa-da.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ZURA_-_Zura-Bio-Limited_-_Market-Capitalization-to-Net-Assets "ZURA zurabio.com Bozor kapitallashuvining balans qiymatiga nisbati (28.04.2023 - 28.10.2026) | 👁️GURU.Markets👁️")
Zura Bio Ltd (ZURA) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Zura Bio Limited|ZURA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Zura Bio Limited|ZURA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Zura Bio Limited|ZURA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Zura Bio
Kompaniyaning dastlabki tahlili:Zura Bio - ZURA
Zura Bio Limited (ZURA) tomonidan immunologik dori vositalarining ishlab chiqilishi butunlay no-tsiklik xarakterga ega va makroiqtisodiy zarbalarga chidamli hisoblanadi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbatini tahlil qilish kompaniyaning bozor qiymatini uning sof aktivlari bilan solishtirish imkonini beradi, bu esa narxlardagi shovqinlarni filtrlash va investitsiya kapitalini himoya qilish uchun aksiyalar qiymatining biznesning moddiy aktivlariga nisbatan haddan tashqari qimmat baholanganlik darajasini aniqlashga xizmat qiladi.
Asosiy raqobatchilar
ARGX: Bozor kapitallashuvining balans qiymatiga nisbati|BNTX (biontech.de) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|SVRA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Rigel Pharmaceuticals Inc|AnaptysBio Inc. (ANAB) - Sof aktivlarga nisbatan bozor kapitallashuvi|ATXS: Kapitallashuvning sof aktivlarga nisbati|ENGN (engene.com) - Bozor kapitallashuvining balans qiymatiga nisbati|RAPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Aerovate|Bozor kapitallashuvining balans qiymatiga nisbati ACRS|Bozor kapitallashuvining balans qiymatiga nisbati Kyverna Therapeutics, Inc KYTX|Kapitallashuvning sof aktivlarga nisbati Tiziana Life Sciences|Balans qiymatiga nisbatan bozor qiymati cabalettabio.com CABA|VTYX - Bozor kapitallashuvining balans qiymatiga nisbati|THTX - Bozor qiymatining balans qiymatiga nisbati|Avalo Therapeutics Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|ELDN (Eledon Pharmaceuticals, Inc) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati AGEN (Agenus)|Bozor qiymatining balans qiymatiga koeffitsiyenti climbbio.com (CLYM)|aTyr Pharma (ATYR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati ADAG (adagene.com)|Bozor qiymatining balans qiymatiga nisbati Ikena Oncology IMA|Bozor qiymatining balans qiymatiga nisbati Shattuck Labs Inc STTK|Bozor kapitallashuvining balans qiymatiga nisbati EQ (Equillium Bio)|CNTB: Balans qiymatiga nisbatan bozor kapitallashuvi|IMUX (immunic-therapeutics.com) - Bozor qiymatining balans qiymatiga nisbati|Atara Bio (ATRA) - Kapitallashuvning sof aktivlarga nisbati|IFRX: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi X4 Pharmaceuticals, Inc (XFOR)|Kapitallashuvning sof aktivlarga nisbati Adicet Bio|Bozor kapitallashuvining balans qiymatiga multiplikatori celularity.com (CELU)|INMB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Barinthus Biotherapeutics PLC BRNS|Kezar Life Sciences, Inc (KZR) - Bozor kapitallashuvining balans qiymatiga nisbati|SAB Biotherapeutics Inc (SABS) - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Akari Therapeutics (AKTX)|Sof aktivlarga nisbatan bozor kapitallashuvi Enlivex Therapeutics Ltd.|QTTB (Q32 Bio Inc) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOVX|Edesa (EDSA) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati iBio Corporation (IBIO)|Bozor kapitallashuvining balans qiymatiga nisbati CARM (Carisma Therapeutics Inc.)|xtlbio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Bolt Bio|HCWB - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati aptevotherapeutics.com APVO|aimimmuno.com (AIM) - Balans qiymatiga nisbatan bozor qiymati|ADTX (Aditxt Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GRI|XORTX Therapeutics (XRTX) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati HIND (Vyome Holdings Inc.)|Revelation Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Indaptus Corp INDP|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|CalciMedica, Inc. (CALI) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati affimed.com AFMD|Allakos (ALLK) - Balans qiymatiga nisbatan bozor qiymati|HOOK: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati OCEA (oceanbiomedical.com)|TC BioPharm - Bozor qiymatining balans qiymatiga nisbati|THRD - Kapitallashuvning sof aktivlarga nisbati